Literature DB >> 18625319

Collybistin is required for both the formation and maintenance of GABAergic postsynapses in the hippocampus.

Theofilos Papadopoulos1, Volker Eulenburg, Suneel Reddy-Alla, Isabelle M Mansuy, Yuqing Li, Heinrich Betz.   

Abstract

Collybistin (Cb) is a brain-specific guanine nucleotide exchange factor, which interacts with the inhibitory receptor anchoring protein gephyrin. In the hippocampus of constitutively Cb-deficient adult mice, gephyrin and gephyrin-dependent GABA(A) receptors (GABA(A)Rs) are lost from postsynaptic sites. Here, we used a Cre-loxP system to inactivate the Cb gene in the forebrain at different developmental stages. Deletion of Cb during embryonic development prevented gephyrin clustering during synaptogenesis and caused an accumulation of gephyrin aggregates in the cell body of CA1 pyramidal neurons. Inactivation of the Cb gene during the third postnatal week resulted in a protracted loss of postsynaptic gephyrin clusters and the appearance of cytoplasmic gephyrin aggregates. These changes in gephyrin distribution were accompanied by a similar reduction in synaptically localized GABA(A)R gamma2-subunit immunoreactivity. Our data show that Cb is required for both the initial localization and maintenance of gephyrin and gephyrin-dependent GABA(A)Rs at inhibitory postsynaptic membrane specializations in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625319     DOI: 10.1016/j.mcn.2008.06.006

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  32 in total

Review 1.  Molecular and functional heterogeneity of GABAergic synapses.

Authors:  Jean-Marc Fritschy; Patrizia Panzanelli; Shiva K Tyagarajan
Journal:  Cell Mol Life Sci       Date:  2012-08       Impact factor: 9.261

Review 2.  Molecular architecture of glycinergic synapses.

Authors:  Thomas Dresbach; Ralph Nawrotzki; Thomas Kremer; Stefanie Schumacher; Daniel Quinones; Martin Kluska; Jochen Kuhse; Joachim Kirsch
Journal:  Histochem Cell Biol       Date:  2008-08-22       Impact factor: 4.304

Review 3.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

4.  Complex role of collybistin and gephyrin in GABAA receptor clustering.

Authors:  Leila Saiepour; Celine Fuchs; Annarita Patrizi; Marco Sassoè-Pognetto; Robert J Harvey; Kirsten Harvey
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

Review 5.  Gephyrin: a key regulatory protein of inhibitory synapses and beyond.

Authors:  Femke L Groeneweg; Christa Trattnig; Jochen Kuhse; Ralph A Nawrotzki; Joachim Kirsch
Journal:  Histochem Cell Biol       Date:  2018-09-27       Impact factor: 4.304

Review 6.  Gephyrin: a master regulator of neuronal function?

Authors:  Shiva K Tyagarajan; Jean-Marc Fritschy
Journal:  Nat Rev Neurosci       Date:  2014-03       Impact factor: 34.870

7.  Collybistin and gephyrin are novel components of the eukaryotic translation initiation factor 3 complex.

Authors:  Andrea L Sertie; Gustavo de Alencastro; Vanessa J De Paula; Maria Rita Passos-Bueno
Journal:  BMC Res Notes       Date:  2010-09-21

Review 8.  Regulation of GABAergic synapse development by postsynaptic membrane proteins.

Authors:  Wei Lu; Samantha Bromley-Coolidge; Jun Li
Journal:  Brain Res Bull       Date:  2016-07-21       Impact factor: 4.077

9.  Gain of FAM123B and ARHGEF9 in an Obese Man with Intellectual Disability, Congenital Heart Defects and Multiple Supernumerary Ring Chromosomes.

Authors:  R Hochstenbach; M E van Gijn; P-J Krijtenburg; R Raemakers; R van 't Slot; I Renkens; M J Eleveld; J J van der Smagt; M Poot
Journal:  Mol Syndromol       Date:  2012-11-20

10.  A conformational switch in collybistin determines the differentiation of inhibitory postsynapses.

Authors:  Tolga Soykan; Daniela Schneeberger; Giancarlo Tria; Claudia Buechner; Nicole Bader; Dmitri Svergun; Ingrid Tessmer; Alexandros Poulopoulos; Theofilos Papadopoulos; Frédérique Varoqueaux; Hermann Schindelin; Nils Brose
Journal:  EMBO J       Date:  2014-07-30       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.